Cargando…
Multiplexing of receptor occupancy measurements for pharmacodynamic biomarker assessment of biopharmaceuticals
BACKGROUND: Receptor occupancy (RO) assays measure drug target engagement, and are used as pharmacodynamic (PD) biomarkers. RO assays are commonly performed by flow cytometry and often require multiplexing for assessment of multiple PD biomarkers when specimen volumes are limited. We present multipl...
Autores principales: | Vainshtein, Inna, Schneider, Amy K., Sun, Bo, Schwickart, Martin, Roskos, Lorin K., Liang, Meina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5057311/ https://www.ncbi.nlm.nih.gov/pubmed/26332491 http://dx.doi.org/10.1002/cyto.b.21319 |
Ejemplares similares
-
Receptor occupancy assessment by flow cytometry as a pharmacodynamic biomarker in biopharmaceutical development
por: Liang, Meina, et al.
Publicado: (2015) -
Quantitative Measurement of the Target-Mediated Internalization Kinetics of Biopharmaceuticals
por: Vainshtein, Inna, et al.
Publicado: (2014) -
Evaluation of assay interference and interpretation of CXCR4 receptor occupancy results in a preclinical study with MEDI3185, a fully human antibody to CXCR4
por: Schwickart, Martin, et al.
Publicado: (2015) -
Molecular Mechanism of HER2 Rapid Internalization and Redirected Trafficking Induced by Anti-HER2 Biparatopic Antibody
por: Cheng, Jackie, et al.
Publicado: (2020) -
Model‐Based Discovery and Development of Biopharmaceuticals: A Case Study of Mavrilimumab
por: Wang, Bing, et al.
Publicado: (2017)